Asset Details
Do you wish to reserve the book?
Design of a multi-epitope vaccine against cervical cancer using immunoinformatics approaches
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Design of a multi-epitope vaccine against cervical cancer using immunoinformatics approaches
Do you wish to request the book?
Design of a multi-epitope vaccine against cervical cancer using immunoinformatics approaches
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Design of a multi-epitope vaccine against cervical cancer using immunoinformatics approaches
2021
Overview
Cervical cancer, caused by human papillomavirus (HPV), is the fourth most common type of cancer among women worldwide. While HPV prophylactic vaccines are available, they have no therapeutic effects and do not clear up existing infections. This study aims to design a therapeutic vaccine against cervical cancer using reverse vaccinology. In this study, the E6 and E7 oncoproteins from HPV16 were chosen as the target antigens for epitope prediction. Cytotoxic T lymphocytes (CTL) and helper T lymphocytes (HTL) epitopes were predicted, and the best epitopes were selected based on antigenicity, allergenicity, and toxicity. The final vaccine construct was composed of the selected epitopes, along with the appropriate adjuvant and linkers. The multi-epitope vaccine was evaluated in terms of physicochemical properties, antigenicity, and allergenicity. The tertiary structure of the vaccine construct was predicted. Furthermore, several analyses were also carried out, including molecular docking, molecular dynamics (MD) simulation, and in silico cloning of the vaccine construct. The results showed that the final proposed vaccine could be considered an effective therapeutic vaccine for HPV; however, in vitro and in vivo experiments are required to validate the efficacy of this vaccine candidate.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
Subject
/ 631/250
/ Antigens
/ Cancer Vaccines - immunology
/ Cervix
/ Cloning
/ Epitopes
/ Female
/ Humanities and Social Sciences
/ Humans
/ Molecular Docking Simulation
/ Oncogene Proteins, Viral - chemistry
/ Oncogene Proteins, Viral - immunology
/ Papillomavirus E7 Proteins - chemistry
/ Papillomavirus E7 Proteins - immunology
/ Papillomavirus Vaccines - chemistry
/ Papillomavirus Vaccines - immunology
/ Repressor Proteins - chemistry
/ Repressor Proteins - immunology
/ Science
/ T-Lymphocytes, Cytotoxic - immunology
/ T-Lymphocytes, Helper-Inducer - immunology
/ Uterine Cervical Neoplasms - immunology
/ Uterine Cervical Neoplasms - prevention & control
/ Uterine Cervical Neoplasms - virology
/ Vaccines
